California Public Employees Retirement System Bridge Bio Pharma, Inc. Transaction History

California Public Employees Retirement System

$141 Billion
Q3 2024

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 04, 2022	SELL	$7.34 - $17.16 $1.32 Million - $3.08 Million	-179,629 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$11.38 - $53.41 $423,688 - $1.99 Million	-37,231 Reduced 17.17%	179,629 $3 Million
Q3 2021 Nov 10, 2021	BUY	$46.87 - $64.24 $51,744 - $70,920	1,104 Added 0.51%	216,860 $10.2 Million
Q2 2021 Aug 13, 2021	SELL	$46.47 - $63.93 $350,523 - $482,223	-7,543 Reduced 3.38%	215,756 $13.2 Million
Q1 2021 May 14, 2021	BUY	$55.47 - $72.35 $2.39 Million - $3.12 Million	43,146 Added 23.95%	223,299 $13.8 Million
Q4 2020 Feb 02, 2021	BUY	$38.38 - $71.11 $568,638 - $1.05 Million	14,816 Added 8.96%	180,153 $12.8 Million
Q3 2020 Nov 05, 2020	BUY	$27.2 - $42.19 $114,240 - $177,198	4,200 Added 2.61%	165,337 $6.2 Million
Q2 2020 Aug 12, 2020	BUY	$22.22 - $35.69 $2.53 Million - $4.07 Million	113,909 Added 241.19%	161,137 $5.26 Million
Q1 2020 May 12, 2020	BUY	$16.11 - $36.23 $156,476 - $351,901	9,713 Added 25.89%	47,228 $1.37 Million
Q4 2019 Jan 27, 2020	BUY	$17.96 - $46.63 $673,769 - $1.75 Million	37,515 New	37,515 $1.32 Million

Others Institutions Holding BBIO

# of Institutions

291

Shares Held

171M

Call Options Held

10.4M

Put Options Held

2.37M

Kohlberg Kravis Roberts & Co. L.P. New York, NY

25.3M
Shares

$592 Million
35.94% of portfolio
Viking Global Investors LP

25.1M
Shares

$588 Million
2.47% of portfolio
Vanguard Group Inc Valley Forge, PA

14.2M
Shares

$333 Million
0.01% of portfolio
Black Rock Inc. New York, NY

12.4M
Shares

$292 Million
0.01% of portfolio
Aisling Capital Management LP New York, NY

6.07M
Shares

$142 Million
63.58% of portfolio

View Full List

About BridgeBio Pharma, Inc.

Ticker BBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 148,246,000
Market Cap $3.47B
Description
BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...

More about BBIO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account